Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns.

Khor YH, Renzoni EA, Visca D, McDonald CF, Goh NSL.

ERJ Open Res. 2019 Sep 16;5(3). pii: 00118-2019. doi: 10.1183/23120541.00118-2019. eCollection 2019 Jul. Review.

2.

Carbon nanotube-mediated DNA delivery without transgene integration in intact plants.

Demirer GS, Zhang H, Goh NS, González-Grandío E, Landry MP.

Nat Protoc. 2019 Oct;14(10):2954-2971. doi: 10.1038/s41596-019-0208-9. Epub 2019 Sep 18.

PMID:
31534231
3.

Silica-associated lung disease: An old-world exposure in modern industries.

Barnes H, Goh NSL, Leong TL, Hoy R.

Respirology. 2019 Dec;24(12):1165-1175. doi: 10.1111/resp.13695. Epub 2019 Sep 13. Review.

4.

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry.

Jo HE, Corte TJ, Glaspole I, Grainge C, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Cooper WA, Mahar AM, Ellis S, Macansh S, Goh NS.

BMC Pulm Med. 2019 May 3;19(1):84. doi: 10.1186/s12890-019-0846-2.

5.

DNA nanostructures coordinate gene silencing in mature plants.

Zhang H, Demirer GS, Zhang H, Ye T, Goh NS, Aditham AJ, Cunningham FJ, Fan C, Landry MP.

Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7543-7548. doi: 10.1073/pnas.1818290116. Epub 2019 Mar 25.

6.

High aspect ratio nanomaterials enable delivery of functional genetic material without DNA integration in mature plants.

Demirer GS, Zhang H, Matos JL, Goh NS, Cunningham FJ, Sung Y, Chang R, Aditham AJ, Chio L, Cho MJ, Staskawicz B, Landry MP.

Nat Nanotechnol. 2019 May;14(5):456-464. doi: 10.1038/s41565-019-0382-5. Epub 2019 Feb 25.

PMID:
30804481
7.

Therapeutic burden in interstitial lung disease: Lessons to learn.

Khor YH, Glaspole I, Goh NSL.

Respirology. 2019 Jun;24(6):566-571. doi: 10.1111/resp.13480. Epub 2019 Feb 20.

8.

Exertional Desaturation and Prescription of Ambulatory Oxygen Therapy in Interstitial Lung Disease.

Khor YH, Goh NS, Glaspole I, Holland AE, McDonald CF.

Respir Care. 2019 Mar;64(3):299-306. doi: 10.4187/respcare.06334. Epub 2018 Oct 30.

PMID:
30377245
9.

Nanoparticle-Mediated Delivery towards Advancing Plant Genetic Engineering.

Cunningham FJ, Goh NS, Demirer GS, Matos JL, Landry MP.

Trends Biotechnol. 2018 Sep;36(9):882-897. doi: 10.1016/j.tibtech.2018.03.009. Epub 2018 Apr 24. Review.

PMID:
29703583
10.

Pulmonary hypertension in combined pulmonary fibrosis and emphysema: A tale of two cities.

Goh NSL.

Respirology. 2018 Jun;23(6):556-557. doi: 10.1111/resp.13289. Epub 2018 Mar 11. No abstract available.

11.

Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary.

Jo HE, Prasad JD, Troy LK, Mahar A, Bleasel J, Ellis SJ, Chambers DC, Holland AE, Lake FR, Keir G, Goh NS, Wilsher M, de Boer S, Moodley Y, Grainge C, Whitford HM, Chapman SA, Reynolds PN, Beatson D, Jones LJ, Hopkins P, Allan HM, Glaspole I, Corte TJ.

Med J Aust. 2018 Feb 5;208(2):82-88.

PMID:
29385965
12.

Cyclophosphamide for connective tissue disease-associated interstitial lung disease.

Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN.

Cochrane Database Syst Rev. 2018 Jan 3;1:CD010908. doi: 10.1002/14651858.CD010908.pub2. Review.

13.

Oxygen Therapy for Interstitial Lung Disease: Physicians' Perceptions and Experiences.

Khor YH, Goh NSL, McDonald CF, Holland AE.

Ann Am Thorac Soc. 2017 Dec;14(12):1772-1778. doi: 10.1513/AnnalsATS.201705-372OC.

PMID:
28796538
14.

Portable oxygen concentrators versus oxygen cylinder during walking in interstitial lung disease: A randomized crossover trial.

Khor YH, McDonald CF, Hazard A, Symons K, Westall G, Glaspole I, Goh NSL, Holland AE.

Respirology. 2017 Nov;22(8):1598-1603. doi: 10.1111/resp.13083. Epub 2017 May 23.

PMID:
28544460
15.

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.

Goh NS, Hoyles RK, Denton CP, Hansell DM, Renzoni EA, Maher TM, Nicholson AG, Wells AU.

Arthritis Rheumatol. 2017 Aug;69(8):1670-1678. doi: 10.1002/art.40130. Epub 2017 Jul 18.

16.

Oxygen Therapy for Interstitial Lung Disease. A Mismatch between Patient Expectations and Experiences.

Khor YH, Goh NSL, McDonald CF, Holland AE.

Ann Am Thorac Soc. 2017 Jun;14(6):888-895. doi: 10.1513/AnnalsATS.201611-934OC.

PMID:
28267349
17.

Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia.

Dowman LM, McDonald CF, Bozinovski S, Vlahos R, Gillies R, Pouniotis D, Hill CJ, Goh NSL, Holland AE.

Respirology. 2017 Jul;22(5):957-964. doi: 10.1111/resp.13002. Epub 2017 Feb 22.

PMID:
28225205
18.

The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.

Dowman LM, McDonald CF, Hill CJ, Lee AL, Barker K, Boote C, Glaspole I, Goh NSL, Southcott AM, Burge AT, Gillies R, Martin A, Holland AE.

Thorax. 2017 Jul;72(7):610-619. doi: 10.1136/thoraxjnl-2016-208638. Epub 2017 Feb 17.

PMID:
28213592
19.

Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.

Glaspole IN, Chapman SA, Cooper WA, Ellis SJ, Goh NS, Hopkins PM, Macansh S, Mahar A, Moodley YP, Paul E, Reynolds PN, Walters EH, Zappala CJ, Corte TJ.

Respirology. 2017 Jul;22(5):950-956. doi: 10.1111/resp.12989. Epub 2017 Feb 6.

20.

Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.

Antoniou KM, Margaritopoulos GA, Goh NS, Karagiannis K, Desai SR, Nicholson AG, Siafakas NM, Coghlan JG, Denton CP, Hansell DM, Wells AU.

Arthritis Rheumatol. 2016 Apr;68(4):1004-12. doi: 10.1002/art.39528.

21.

Agreement and mortality prediction in high-resolution CT of diffuse fibrotic lung disease.

Siemienowicz ML, Kruger SJ, Goh NS, Dobson JE, Spelman TD, Fabiny RP.

J Med Imaging Radiat Oncol. 2015 Oct;59(5):555-63. doi: 10.1111/1754-9485.12314. Epub 2015 May 12.

PMID:
25963240
22.

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.

De Lauretis A, Sestini P, Pantelidis P, Hoyles R, Hansell DM, Goh NS, Zappala CJ, Visca D, Maher TM, Denton CP, Ong VH, Abraham DJ, Kelleher P, Hector L, Wells AU, Renzoni EA.

J Rheumatol. 2013 Apr;40(4):435-46. doi: 10.3899/jrheum.120725. Epub 2013 Feb 1.

PMID:
23378460
23.

Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

Corte TJ, Goh NS, Glaspole IN, Zappala CJ, Hopkins PM, Wilsher ML.

Thorax. 2013 May;68(5):491-2. doi: 10.1136/thoraxjnl-2012-203114. Epub 2013 Jan 23. No abstract available.

PMID:
23345573
24.

The six-minute walk test in scleroderma: what should we measure and how should we measure it?

Holland AE, Goh NS.

Respirology. 2012 May;17(4):588-9. doi: 10.1111/j.1440-1843.2012.02161.x. No abstract available.

PMID:
22394399
25.

Increased epithelial permeability in pulmonary fibrosis in relation to disease progression.

Goh NS, Desai SR, Anagnostopoulos C, Hansell DM, Hoyles RK, Sato H, Denton CP, Black CM, du Bois RM, Wells AU.

Eur Respir J. 2011 Jul;38(1):184-90. doi: 10.1183/09031936.00010910. Epub 2010 Oct 28.

26.

Differentiating between IPF and NSIP.

Glaspole I, Goh NS.

Chron Respir Dis. 2010 Aug;7(3):187-95. doi: 10.1177/1479972310376205. Review.

PMID:
20688895
27.

Interstitial lung disease in systemic sclerosis: a simple staging system.

Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27.

PMID:
18369202
28.

A 43-year-old chinese man with a retro-orbital mass.

Tan HW, Goh NS, Yap WM, Chuah kL.

Brain Pathol. 2008 Jan;18(1):96-7, 139. doi: 10.1111/j.1750-3639.2007.00115_1.x. No abstract available.

PMID:
18226099
29.

Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma.

Thong PS, Ong KW, Goh NS, Kho KW, Manivasager V, Bhuvaneswari R, Olivo M, Soo KC.

Lancet Oncol. 2007 Oct;8(10):950-2. No abstract available.

PMID:
17913664
30.

Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.

Goh NS, Veeraraghavan S, Desai SR, Cramer D, Hansell DM, Denton CP, Black CM, du Bois RM, Wells AU.

Arthritis Rheum. 2007 Jun;56(6):2005-12.

31.

Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.

Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM.

Clin Exp Dermatol. 2007 Jul;32(4):353-8. Epub 2007 Apr 13. Review.

PMID:
17433041
32.

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.

Arthritis Rheum. 2006 Dec;54(12):3962-70.

33.

CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.

Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, Colby TV, Denton CP, Black CM, du Bois RM, Wells AU.

Radiology. 2004 Aug;232(2):560-7.

PMID:
15286324
34.

Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.

Tan HM, Chan LL, Chuah KL, Goh NS, Tang KK.

Br J Radiol. 2004 Feb;77(914):153-6.

PMID:
15010391
35.

Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.

Goh NS, McDonald CE, MacGregor DP, Pretto JJ, Brodie GN.

Respirology. 2003 Mar;8(1):91-4.

PMID:
12856748
36.

Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby TV, du Bois RM, Hansell DM.

Am J Respir Crit Care Med. 2003 Apr 1;167(7):962-9.

PMID:
12663338

Supplemental Content

Support Center